SCHEMBL254738

SCHEMBL254738

CC(C)(O)[C@H](N)C(=O)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL223812 1.00
SCHEMBL223813 1.00
Hydrochloric Acid SCHEMBL20299896 0.97 ALDH1A1 (0.56)
Hydrochloric Acid SCHEMBL20299895 0.97 ALDH1A1 (0.56)
Nitrous Acid SCHEMBL1414648 0.90 ALDH1A1 (0.50)
SCHEMBL8673266 0.82
SCHEMBL27548159 0.82
SCHEMBL6433 0.79
SCHEMBL6672007 0.79 ALDH1A1 (0.62)
SCHEMBL7396758 0.79 ALDH1A1 (0.62)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 717 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260042800-A1 ANTIMICROBIAL PEPTIDOMIMETICS BASILEA PHARMACEUTICA INT AG ALLSCHWIL (CH) 2026-02-12 US claimed
US-20250276073-A1 BICYCLIC PEPTIDE LIGANDS SPECIFIC FOR TRANSFERRIN RECEPTOR 1 (TfR1) BICYCLETX LIMITED (GB) 2025-09-04 US claimed
EP-4519299-A1 BICYCLIC PEPTIDE LIGANDS SPECIFIC FOR TRANSFERRIN RECEPTOR 1 (TFR1) BicycleTx Limited (GB) 2025-03-12 EP claimed
US-20240228555-A9 ANTIMICROBIAL PEPTIDOMIMETICS BASILEA PHARMACEUTICA INTERNATIONAL AG, ALLSCHWIL (CH) 2024-07-11 US claimed
CN-112912383-B Peptide compounds 优拓制药公司 2024-07-05 CN claimed
US-20240132553-A1 ANTIMICROBIAL PEPTIDOMIMETICS SPEXIS AG (CH) 2024-04-25 US claimed
CN-117865567-A Environment-friendly high-strength pervious concrete and preparation method thereof 江西国桢建材有限责任公司 2024-04-12 CN claimed
WO-2023214162-A1 BICYCLIC PEPTIDE LIGANDS SPECIFIC FOR TRANSFERRIN RECEPTOR 1 (TfR1) BICYCLETX LIMITED (GB) 2023-11-09 WO claimed
EP-4267590-A1 ARGINASE INHIBITORS AND METHODS OF USE THEREOF ONCOARENDI THERAPEUTICS S.A. (PL) 2023-11-01 EP claimed
EP-4214220-A1 ANTIMICROBIAL PEPTIDOMIMETICS Spexis AG (CH) 2023-07-26 EP claimed
EP-0560274-B1 Antiherpes peptide derivatives having a ureido N-terminus BOEHRINGER INGELHEIM CA LTD (CA) 1998-06-24 EP claimed
US-5756650-A COMPOSITION COMPRISING POLYAMIC ACID, CURE ACCELERATOR SELECTED FROM GROUP CONSISTING OF NITROGEN-CONTAINING HETEROCYCLIC COMPOUND, AMINO ACID COMPOUND, AROMATIC COMPOUND HAVING TWO OR MORE HYDROXYL GROUPS KABUSHIKI KAISHA TOSHIBA (JP) 1998-05-26 US claimed
JP-H08507760-A 1996-08-20 JP claimed
CN-1118601-A Inhibitors of herpes viral ribonucleotide reductase BIO MEGA BOEHRINGER INGELHEIM (CA) 1996-03-13 CN claimed
US-5476841-A Inhibitors of herpes viral ribonucleotide reductase BIO-MEGA/BOEHRINGER INGELHEIM RESEARCH INC. (CA) 1995-12-19 US claimed
EP-0618226-A1 Inhibitors of herpes viral ribonculeotide reductase BIO-MEGA/BOEHRINGER INGELHEIM RESEARCH INC. (CA) 1994-10-05 EP claimed
WO-1994020528-A1 INHIBITORS OF HERPES VIRAL RIBONUCLEOTIDE REDUCTASE BIO-MEGA/BOEHRINGER INGELHEIM RESEARCH INC. (CA) 1994-09-15 WO claimed
WO-1993018056-A1 ISOSTERIC ANTIHERPES PEPTIDE DERIVATIVES BIO-MEGA/BOEHRINGER INGELHEIM RESEARCH INC. (CA) 1993-09-16 WO claimed
EP-0560274-A1 Antiherpes peptide derivatives having a ureido N-terminus BIO-MEGA/BOEHRINGER INGELHEIM RESEARCH INC. (CA) 1993-09-15 EP claimed
EP-0560267-A1 Isosteric antiherpes peptide derivatives BIO-MEGA/BOEHRINGER INGELHEIM RESEARCH INC. (CA) 1993-09-15 EP claimed